Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations

BACKGROUND: IPX066 is an extended-release (ER) oral formulation of carbidopa-levodopa (CD-LD). Following an initial peak at about one hour, plasma LD concentrations are maintained for about 4-5 hours. OBJECTIVE: To present dosing factors that may affect the successful conversion to ER CD-LD from oth...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Parkinsons Dis
Egile Nagusiak: Morgan, John C., Dhall, Rohit, Rubens, Robert, Khanna, Sarita, Gupta, Suneel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2018
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217748/
https://ncbi.nlm.nih.gov/pubmed/30425824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9763057
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak